In clinical practice, the finding of an elevated mean corpuscular volume (M
CV), macrocytic anaemia or specific neurological symptoms is often the reas
on to test for vitamin B12 (B12) deficiency. Use of the MCV as a test for t
he detection or exclusion of B12 deficiency is only justified if the diagno
stic accuracy is sufficiently high. However, the sensitivity and specificit
y are not well known. We performed a systematic review of the diagnostic va
lue of an elevated MCV for B12 deficiency in both anaemic and non-anaemic p
atients. Of approximately 3500 titles and/or abstracts that were screened,
37 original papers contained usable data. The population under study proved
to be the characteristic of major influence on the study outcome. Pooling
of data from different studies was performed in subsets of the data corresp
onding to the different populations studied. The cut-off levels of both MCV
and serum B12 had a significant influence on the study outcomes. The data,
however, were pooled without taking these cut-off levels into account. The
pooled estimates should be interpreted with this limitation in mind. The r
eference standards were (1) a low serum B12 concentration and (2) a B12 def
iciency confirmed by low serum B12 combined with additional diagnostic inve
stigations. In the population that was randomly screened for low serum B12,
the sensitivity of the MCV for B12 deficiency was 17%, whereas the sensiti
vity was 30% for B12 deficiency in patients with anaemia. When measurement
of serum B12 was ordered to exclude B12 deficiency as part of the patients'
treatment, the sensitivity was 30% for low serum B12 concentration, 58% fo
r B12 deficiency and 75% for B12 deficiency in patients with anaemia. In th
e population with pernicious anaemia, the sensitivity was far from perfect
(77%). In the five studies that reported data on the positive predictive va
lue of the MCV for B12 deficiency, this ranged from 0% (0/6) to 55% (11/20)
. This systematic review shows that a considerable number of B12-deficient
patients will remain unnoticed when the MCV is used to rule in patients for
further evaluation. Depending on the population studied, up to 84% of case
s will than be missed. The: MCV can be used to make the diagnosis of B12 de
ficiency more-or less- probable. An elevated MCV justifies the measurement
of serum B12. The MCV should not be used as the only parameter ruling out t
he diagnosis of B12 deficiency.